Specific Nrf2 knockdown in adipose tissue attenuates obesity-induced adipose tissue inflammation by inhibiting the cGAS-STING pathway, providing a novel therapeutic strategy targeting the adipose-specific antioxidant-inflammatory regulatory network. Here, CGAS is linked to obesity disorder.